SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-21-071020
Filing Date
2021-05-24
Accepted
2021-05-24 13:46:50
Documents
1
Group Members
DR. JAMES I. HEALYDR. MAHA KATABIDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT X, L.L.C

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2117349d1_sc13d.htm SC 13D 116509
  Complete submission text file 0001104659-21-071020.txt   118167
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners X, L.P. (Filed by) CIK: 0001680200 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Subject) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92556 | Film No.: 21953381
SIC: 2834 Pharmaceutical Preparations